Although, within the INCA study, no increased risk was shown for doctor's diagnosed eczema after neonatal antibiotic treatment at 1 year of age (10), increased concentrations of Gal-3, CCL17 (TARC), and CCL18 (PARC) were detected within the infants with DDE. Here, LGALS3 is linked to Eczematoid dermatitis.